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Abstract
Evaluative bibliometrics uses advanced techniques to assess the impact of scholarly work in the context of other scientific
work and usually compares the relative scientific contributions of research groups or institutions. Using publications from
the National Institute of Allergy and Infectious Diseases (NIAID) HIV/AIDS extramural clinical trials networks, we assessed the
presence, performance, and impact of papers published in 2006–2008. Through this approach, we sought to expand
traditional bibliometric analyses beyond citation counts to include normative comparisons across journals and fields,
visualization of co-authorship across the networks, and assess the inclusion of publications in reviews and syntheses.
Specifically, we examined the research output of the networks in terms of the a) presence of papers in the scientific journal
hierarchy ranked on the basis of journal influence measures, b) performance of publications on traditional bibliometric
measures, and c) impact of publications in comparisons with similar publications worldwide, adjusted for journals and fields.
We also examined collaboration and interdisciplinarity across the initiative, through network analysis and modeling of co-
authorship patterns. Finally, we explored the uptake of network produced publications in research reviews and syntheses.
Overall, the results suggest the networks are producing highly recognized work, engaging in extensive interdisciplinary
collaborations, and having an impact across several areas of HIV-related science. The strengths and limitations of the
approach for evaluation and monitoring research initiatives are discussed.
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Introduction
In 2006, the US National Institute of Allergy and Infectious
Diseases (NIAID) restructured its system of extramural HIV/
AIDS clinical trials networks prompted by changes in the
infectious disease knowledge base, the unabated expansion and
shifting demographics of the epidemic, the size and complexity of
the enterprise, and fiscal considerations. The six networks are the
AIDS Clinical Trials Group, HIV Prevention Trials Network,
HIV Vaccine Trials Network, Microbicide Trials Network,
International Maternal Pediatric and Adolescent Trials Network,
and the International Network for Strategic Initiatives in Global
HIV Trials. Six scientific priority areas were identified [1] and, an
extensive participatory evaluation planning effort was undertaken
[2]. During this process, system stakeholders identified several key
areas for evaluation, with highest priority given to the assessment
of the networks’ scientific agendas and biomedical research
objectives. More specifically, the extent to which network research
is highly influential, addressing the highest priority research
questions, making significant progress in planned research, and
informing standards of care or clinical guidelines were viewed as
key evaluation questions. This report presents results from
bibliometric analyses based on the networks’ research publication
record for the period 2006–2008 and considers the strengths and
drawbacks of this approach in assessing the impact and
performance of scientific research output for this (and potentially
other) clinical trials programs.
Bibliometric studies of HIV research
Previous bibliometric studies describing publication trends and
patterns in HIV research provided a base of understanding for the
ways bibliometrics might be applied to the evaluation of the
scientific output from the NIAID HIV/AIDS clinical trials
networks. A co-citation analysis of HIV research completed in
the early years of the epidemic traced the expansion of the field
and shifts in study foci [3]. Further, bibliometric studies of the
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of new scientific terminology and the specialization of journals as
the field progressed [4–6]. The emergence of the study of HIV as
an interdisciplinary field of research, coupled with the advance-
ment of bibliometric methods over the past 25 years, has enabled
researchers to better assess collaboration patterns, geographic
distribution, and expansion of subject areas and content of the
science. Reflecting the global scientific effort to address the
epidemic, an array of bibliometric studies of research output in
international settings [7–14], as well as work documenting the
productivity and collaboration between different world regions
have been published [15].
While these earlier bibliometric studies of HIV research have
described the distribution and variation in the scientific output
over time, the use of bibliometric methods to determine the
baseline level of performance and impact of research output from
a large system of HIV clinical trials research has not been carried
out previously. To that end, our purpose was to assess the
presence, performance, and impact of scientific publications by the
NIAID HIV/AIDS clinical trials networks since the 2006
reorganization through a comprehensive bibliometric evaluation
that included normative comparisons, collaborative network
analyses, and inclusion in research syntheses.
Methods
Evaluation of scientific output
The evaluation of scientific work is among the key driving forces
behind modern scientific advancements. Evaluative bibliometrics
seeks to assess the impact of scientific output in the context of other
published science and usually compares the relative scientific
contributions of research groups or institutions. Several evalua-
tions of large, publicly-funded research programs have conducted
bibliometric analysis as one component of a comprehensive and
integrated evaluation approach designed to assess processes and
outcomes of scientific initiatives using quantitative indicators that
enable aggregation of output [16–18]. While the application of
bibliometrics to aggregate and analyze the scientific output across
research units and centers has increased, the use of such data for
evaluation within a specific research enterprise requires a clear
purpose, context, and understanding of the limitations.
Bibliometrics involves the quantitative assessment of the
occurrence of certain events in the scientific literature, as opposed
to the analysis and interpretation of the literature’s content. The
use of bibliometrics relies on the very structured nature and
expectations of the refereed scientific literature. The primary
assumption supporting the use of bibliometrics is that exchange
and recognition of research results is desired and is one of the key
driving forces in the advancement of science [19]. Citations
symbolize the association of scientific ideas, and the references
which authors cite in their papers make explicit the link between
their current research and prior work in the scientific literature
archive. Therefore, the analysis of publication data can help
quantify the performance and impact of a given set of publications
produced by an entity as it relates to the exchange and
dissemination of results.
Results from bibliometric analyses can be a critically important
source of objective information about the quantity and quality of
scientific work. Three basic tenets underlying advanced biblio-
metric analyses have been emphasized in the literature: a) activity
measurement; b) impact measurement, and c) linkage measure-
ment [20]. Of these three tenets, impact measurement has been
the most tenuous, conceptually and methodologically. Because of
the well-known limitations of bibliometric data, claims of impact
have been extensively debated. However, as the use of bibliometric
methods to evaluate scientific outcomes has increased in recent
years, so too has the attention to the fundamental concepts,
language, techniques, and implications for evaluation. Further-
more, new network analysis and visualization techniques are being
used more frequently to model complex relationships of scientific
output.
In our assessment of the performance and impact of the
research output from the NIAID HIV/AIDS clinical trials
networks, we followed the advanced bibliometric methods
approach for monitoring and evaluating research units outlined
by the Center for Science and Technology Studies at Leiden
University [21–23]. One strand of this approach focuses on
research performance evaluation of a well-defined entity and is
particularly useful in new problem-oriented interdisciplinary fields.
The other focuses on defining an emerging field of interdisciplin-
ary research where the boundaries are not clearly established. The
evaluation of the scientific output of the NIAID HIV/AIDS
clinical trials networks presented the opportunity to employ
techniques from both strands to describe the impact of the current
research in the context of an expanding interdisciplinary scientific
landscape.
In evaluating the NIAID HIV/AIDS clinical trials networks as
an entity, we examined the research output in terms of its presence
in the scientific journal hierarchy, performance of publications on
widely accepted bibliometric measures, and impact of the research
relative to other papers published worldwide. Through the
creation of a research profile of publication performance and
impact across journal fields [21] we sought to identify specific fields
in which publications from the networks were exhibiting the
greatest performance and impact in the relevant scientific
literature. Additionally, we isolated a set of highly performing
papers to analyze their presence, performance, and impact across
a variety of fields and journals. Lastly, in order to look at
interdisciplinarity, we examined international cooperation and co-
authorship patterns, as well as the inclusion of papers in reviews
and information syntheses.
Data source and sample
Each of the six clinical research networks (i.e., AIDS Clinical
Trials Group, HIV Prevention Trials Network, HIV Vaccine
Trials Network, Microbicide Trials Network, International
Maternal Pediatric and Adolescent Trials Network, and the
International Network for Strategic Initiatives in Global HIV
Trials) was asked to submit a list of its network supported
publications appearing in peer-reviewed journals between 2006
and 2008. All networks complied and provided a combined
electronic bibliography of 450 publications for the specified
period. After verifying the full bibliographic entry for each article
in PubMed, the final set of 450 articles was searched via the ISI-
Thomson Web of Science (WoS) platform. WoS is the leading
source for bibliometric citation databases and includes the Science
Citation Index-Expanded and the Social Science Citation Index
databases.
For retrieving journal specific citation metrics, the ISI Journal
Citation Report (JCR) database was used. The JCR Science
Edition indexes 7,350 leading peer-reviewed journals in 171
different subject categories and more than 2,242 leading peer-
reviewed journals in 55 subject categories in its Social Science
Edition. Both editions were used to retrieve field specific journal
rankings. Approximately 25 million citations are processed
annually for inclusion in the JCR database making it the most
robust journal citation database available. We used these to
Evaluative Bibliometric Analysis
PLoS ONE | www.plosone.org 2 March 2011 | Volume 6 | Issue 3 | e17428benchmark and rank journals containing the NIAID HIV/AIDS
clinical trials networks papers.
The initial extraction of citation data for the 450 articles yielded
426 matches, based on correspondence between indexed journals
in the WoS databases and those found in the bibliography
submitted by the networks. The 24 unmatched papers were
published in journals that were not indexed in the scientific
publication databases because they did not meet multi-component
review criteria for peer-review quality or coverage. Two journals
publishing five network articles, (AIDS Research and Therapy and
PLoS One) had been evaluated in the past but not been accepted for
indexing at the time of extraction due to the absence of a
uniformly applied, formal peer review. Several other journals on
the excluded list, including Research Practitioner (6 network articles)
were not peer review journals, but as in the case of Research
Practitioner, ‘‘edited with the highest editorial standards’’. These
journals were not indexed in either PubMed or MEDLINE as
well. Although the WoS databases do not include all journals or
capture every published article across fields, it is currently the best
set of information available to examine the extent to which
network publications are present in the overall body of HIV/AIDS
literature.
The citation data from the 426 source articles referenced above
were extracted and imported into a Microsoft Access database that
allowed computation and analysis of citation information. Seven
articles included in the extracted data set fell outside the 2006–
2008 time period due to differences in the publication year
recorded in the WoS databases. These papers were subsequently
excluded from the bibliometric analyses. Thus, a final set of 419
publications met the timeframe requirements and had the citation
data needed for the analyses described in this report.
Results
Descriptive findings
The 419 papers included in the analysis were published in 114
journals indexed by Thomson-ISI within the JCR database.
Approximately 75% of the network papers were cited at least
once. Overall, the 419 network papers were cited 2,582 times
within 1,996 papers published in 549 indexed journals. Publica-
tions from the networks averaged 6.16 citations per paper with a
median cite of 2. The number of citations ranged from 0 to 170.
Over the three year period, 124 papers (29.5%) were uncited, after
adjusting for self-citations. Self-citations refer to citations by any
authors identical to those found on the cited paper. Because higher
author self-citation rates can inflate the number of citations, the
author self-citation rate was calculated for this set of papers to
determine if the self-citation rate was substantial. Since many
articles had multiple authors, and not all authors were researchers
from the NIAID HIV/AIDS clinical trials networks, it was
possible that self-citation included citation of an article by a non-
network co-author. Based on the total number of citations for all
419 papers and the number of self-cites among all authors named
for each publication (528), we found a self-cite rate of slightly more
than 20% (20.4%). Studies have shown that authors working in
research-based disciplines tend to cite themselves between 10%
and 30%, depending upon the field of study [23–25]. Thus, the
self-cite rate for the papers from the NIAID HIV/AIDS clinical
trials networks is within the ‘normative’ range for author self-
citation, despite the high level of co-authorship.
Presence in journal hierarchy
Journals are not homogeneous outlets of science in terms of
their audiences, visibility, significance, and readership. Across
fields of research, great value is placed on journals with higher
status and perceived levels of productivity and therefore attracts
large international audiences from the scientific community.
Journals with the propensity to draw a great deal of attention to
the papers it publishes are held in high regard and widely
recognized across international settings. Requirements for pub-
lishing in these journals are often stringent and review processes
particularly demanding. Therefore, analyses that reveal where a
set of papers reside in the journal hierarchy is important to
evaluating the presence of a set of papers across scientific fields.
In our examination of the journals in which papers from the
NIAID HIV/AIDS clinical trials networks were published, we
found the 419 papers were published in 114 different journals,
with the number of publications per journal ranging from 57 to 1.
The average Journal Citation Report (JCR) impact factor for
journals containing the set of 419 papers was 5.82 and values
ranged from .16 to 52.59. Using the widely-available JCR impact
factors as preliminary means for ranking journals we found 47 of
the 114 journals (41.2%) publishing papers from the NIAID HIV/
AIDS clinical trials networks were in the top 10% of all scientific
journals indexed by Thomson-ISI. The average impact factor of
this select group of 47 journals was 9.74, with nearly two-thirds of
all of the network papers (n=271; 65%) published in journals at
this high level. This set of 271 papers published in the upper tier of
scientific journals received 84.8% (2,189) of all citations attributed
to publications from the NIAID HIV/AIDS clinical trials
networks and the percentage of papers that were cited one or
more times, including self-citations, was 81.2%. Thus, the majority
of papers from the networks were published in highly productive
and visible journals, based on a global ranking and therefore
obtaining a substantial proportion of citations. Not surprisingly,
more than one third of the papers from the NIAID HIV/AIDS
networks (35.3%) were published in 3 specific journals: AIDS (JCR
impact factor=5.84), Journal of Acquired Immune Deficiency Syndromes
(JCR impact factor=4.41), and Journal of Infectious Diseases (JCR
impact factor=5.84) reflecting the trend of publication of AIDS
research output in specialized journals over the past decade [3].
Overall performance and impact of research output
To assess the performance of the set of 419 papers from the
NIAID HIV/AIDS networks, we calculated the total number of
citations for the set (C) and citations per paper (CPP) by year and
publication type. Following procedures and terminology outlined
by Center for Science and Technology Studies at Leiden
University for assessing impact of a set of papers relative to those
published worldwide, we accessed: a) the average total number of
citations of a certain article type (abstract, article, review, note,
etc.) published in a specific journal cumulatively by the most recent
completed year (Journal Citation Score; JCS), and; b) the average
number of citations for all articles that were published in a
particular year, in all journals in a specific field (Field Citation
Score; FCS) from the JCR database. The JCS represents the
number of citations one would expect for a paper of the same type,
published in the same journal, in the same year and serves as an
international reference to compare relative impact of publications
to those published in specific journals. The FCS represents the
number of citations one would expect for a paper of the same type,
published in all journals within a specific field in the same year,
and serves as an international reference to compare relative
impact of publications to those published in the group of journals
that constitute a field. Next we summed all of the citations to the
papers published by the NIAID HIV/AIDS networks for 2006–
2008. We then summed all of the corresponding JCS values for
each paper and calculated a journal normalized measured impact
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FCS values for each paper and calculated a field normalized
measured impact ratio (CPP/FCSm) [21]. In both cases,
normalization of the citation values is completed at the group
level after summing the world averages that correspond to the
selected publications with respect to the publication type, age, and
journal (for the JCS) or subject area (for the FCS) and then
dividing it by the number of citations for the set of publications.
The results of the performance and impact of the NIAID HIV/
AIDS clinical trials networks’ publications is included in Table 1.
A ratio of 1.0 indicates that the set of publications have met the
expected number of citations based on the journals in which they
were published. For the collection of 419 papers, the CPP/JCSm
ratio was 1.12, indicating the papers from the NIAID HIV/AIDS
clinical trials networks were cited 12% above average across the set
of journals publishing papers produced by the networks. The
CPP/FCSm ratio was 1.90, indicating the papers from the NIAID
HIV/AIDS clinical trials networks were cited 90% above the
worldwide average across relevant fields. In terms of evaluating the
level of impact, generally accepted international impact standards
for interpreting both the CPP/JCSm and CPP/FCSm ratios have
been published [21–23]. Specifically, the levels are: far below
average (indicator value,0.5); below average (indicator value 0.5–
0.8); average (0.8–1.2); above average (1.2–1.5); and far above
average (.1.5). Thus, the impact of the network papers within the
published journal set was above average and the impact of the
network papers in the fields was far above average. We further
evaluated the global standing of the journal set containing the
papers from the NIAID HIV/AIDS clinical trials networks relative
to the fields in which the journal belong. The JCSm/FCSm ratio
was 1.73, indicating the mean citation score of the network’s
journal set exceeded the mean citation score for all articles
published in the fields to which the journals belong. Thus, the
networks as a group publish in journals with a high impact in the
fields of study with relevance to HIV.
Profile of interdisciplinary research
An important part of advanced bibliometric performance and
impact evaluation is the construction and representation of a
research profile for a specific entity [21,23]. A research profile is a
breakdown of output, performance, and impact according to
internationally defined research fields on the basis of the journals
used by the entity. In an effort to examine the variation in
presence, performance, and impact of NIAID HIV/AIDS clinical
trials networks papers in relation to a wide variety of scientific
areas of study we conducted an analysis of bibliometric indicators
by fields (i.e. ISI’s Current Content Categories). Each paper
(except letters, editorials, and meeting abstracts) is assigned a main
field category label by Thomson-ISI and extracted from JCR. In
our analysis, 29 of the 419 papers were not assigned a field
category because of their type, resulting in a final set of 390 papers
(general article and reviews) for the field analysis and profile
generation.
The 390 NIAID HIV/AIDS clinical trials networks papers were
distributed across 41 distinct field categories, reflecting a wide
range of disciplines, although more than 36% (15) of the fields
included only a single publication. Within these 41 fields, we first
assessed the position of network papers as a means for
understanding their presence, relative to the status of the journals
within each field. To determine the status of each journal within
each field, we rank-ordered the journals within each field by their
Eigenfactor score [26]. The Eigenfactor score is a measure of the
total influence of a journal based on cross-citation patterns. The
Eigenfactor score provides several advantages to the JCR impact
factor because it uses the 5 previous years for the target window
and excludes self-citations. Thus, the ranking of a journal in a field,
based on Eigenfactor score, is a robust indicator of the overall
influence of the journal within the field [27]. Second, to determine
performance of papers across fields, the total number of citations
(C) and citations per paper (CPP) for the set of papers within each
field was calculated. Finally, in terms of assessing impact of the
papers across fields, we again calculated the field normalized
measured impact ratios (CPP/FCSm) of NIAID HIV/AIDS clinical
trials networks’ publications for each field.
Overall, the scientific strength and international visibility of the
NIAID HIV/AIDS clinical trials networks’ publications across
fields was high to very high. Nearly three-fourths (74.7%) of the
390 papers were published in the top quartile of ranked journals
across fields. Furthermore, slightly more than one-third (35.2%)
were published in the first, second, or third ranked journal in their
respective fields. Table 2 displays the distribution of NIAID HIV/
AIDS clinical trials networks’ publications across fields, along with
the respective positioning of publications within each field’s
journal hierarchy.
In terms of the impact assessment within each field, Infectious
Diseases (C=1070) had the largest number of citations, followed
by Medicine, General and Internal (C=443), reflecting the
primary biomedical research focus the of NIAID HIV/AIDS
clinical trials networks. The largest citations per paper values were
found in the fields of Medicine, General and Internal
(CPP=22.15); Medicine, Research and Experimental
(CPP=19.63); and Clinical Neurology (CPP=10.67) suggesting
that NIAID HIV/AIDS clinical trials networks research is
generating substantial interest in these disciplines. Figure 1
provides a spectral analysis of the research output of the NIAID
HIV/AIDS clinical trials networks across those fields with more
than a 1% share in the total number of publications. The color of
the shaded bar corresponds to the average field normalized score
for the set of papers published within the respective field. Results
revealed that of the 17 fields with more than 1% of the total share
of publications, the largest impact (CPP/FCSm above 2.5) was seen
in the fields of Medicine, General and Internal; Medicine,
Research and Experimental; and Clinical Neurology. A lower,
but still substantial impact level (CPP/FCSm above 1.5) was also
observed and included the fields of Microbiology; Pediatrics;
Virology; Psychology, Multidisciplinary; Infectious Diseases; and
Obstetrics and Gynecology. The field normalized citation scores
indicated that publications in these fields were highly influential
and visible, far exceeding the number of citations expected for
publications of the same age and type in the respective fields. Even
Table 1. Performance and impact indicators for all NIAID HIV/
AIDS clinical trials networks publications, 2006–2008.
Group P C CPP
CPP/
JCSm
CPP/
FCSm
JCSm/
FCSm
All network
publications
419 2582 6.16 1.12 1.90 1.74
2008 publications 119 119 1.00 1.02 1.02 1.77
2007 publications 152 668 4.39 1.07 1.95 1.54
2006 publications 148 1795 12.13 1.15 2.03 1.77
Note: P=number of articles published; C=total number of citations;
CPP=average number of citations per publication; JCSm=average expected
citations for a journal set; FCSm=average expected citations across a
combination of fields.
doi:10.1371/journal.pone.0017428.t001
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measured impact of those papers was still high.
Identification and impact of top papers
While the overall impact of the entire set of network papers was
found to be slightly above the international averages for both
journal and fields, we were also interested in identifying a subset of
publications that might be making a substantive impact across
HIV research environments. To that end, first we isolated a
collection of papers that were determined to have the necessary
number of citations needed to make a publication one of the 10%
most cited publications of the same age, type, and within the same
field. The number of papers within the top 10% of the worldwide
impact distribution has been considered a robust indicator of
scientific excellence in previous bibliometric studies [23,28,29]. At
the 10% highly-cited threshold, 72 network papers were found,
representing 18.5% of the total network publications. It was
important to distinguish the nature of each of these papers, as it
was anticipated that citation patterns vary as a function of the type
of publication across this very interdisciplinary environment.
Therefore, we categorized each of the 72 papers into one of six
types, in order to help understand the differences in use and
acceptance across fields. Papers were classified as follows: Primary
publications - the ‘main’ publication from a research protocol
reporting on the primary objectives; Secondary publications -
additional protocol publications reporting results on secondary
and/or tertiary endpoints; Review articles, Cross-protocol analy-
ses, External collaborative research (typically with investigators
from outside of a network), Observational studies, and Other (e.g.
non-network supported study where network investigators were
included as authors). For the categorization, each publication was
independently reviewed by two authors (JK and JS) and consensus
reached with a third (SR).
The results of the categorization of the 72 highly-cited papers
revealed that nearly one third (31%) were publications detailing
the primary results of a specific study protocol. Not surprising,
nearly all of the primary study results publications were in the field
of Infectious Diseases. Twenty-four percent were collaborative
studies with groups outside of the networks, 18% were publications
focused of results of secondary analyses, 12% were reviews, 6%
were observational studies, 5% were cross protocol studies, and
4% were classified as other. This set of 72 papers was published in
26 different journals and acquired a total of 1,522 citations. They
averaged 21.14 citations per paper with a median of 14.5. More
than half (56.9%) were published in the core HIV-related fields of
Infectious Diseases, Microbiology, and Virology. The average
Table 2. Distribution of NIAID HIV/AIDS clinical trials networks’ papers in journal hierarchy by field category (fields with 2 or more
publications).
Field Category N Cites
Average cites
per paper
# of papers in top quartile of
ranked journals within field
# of papers in 1, 2, or 3
ranked journal within field
Infectious Diseases 169 1070 6.3 138 46
Pharmacology & Pharmacy 45 149 3.3 23 12
Medicine, General Internal 20 443 22.2 18 12
Virology 19 126 6.6 15 15
Microbiology 15 121 8.1 15 7
Public, Environmental & Occupational Health 12 32 2.7 5 4
Immunology 12 21 1.8 8 2
Clinical Neurology 9 96 10.7 7 6
Pediatrics 9 29 3.2 9 8
Medicine, Research & Experimental 8 157 19.6 1 1
Obstetrics and Gynecology 8 28 3.5 8 7
Statistics & Probability 6 20 3.3 4 0
Biomedical Research Methods 5 25 5.0 0 0
Medical Laboratory Technology 5 22 4.4 4 1
Chemistry, Analytical 4 25 6.3 2 0
Psychology, Multidisciplinary 4 11 2.8 4 0
Social Sciences, Biomedical 4 6 1.5 4 0
Biotechnology & Applied Microbiology 3 14 4.7 2 0
Healthcare Sciences & Services 3 8 2.7 2 1
Endocrinology & Metabolism 3 7 2.3 2 2
Biochemistry & Molecular Biology 2 8 4.0 1 0
Mathematical & Computational Biology 2 9 4.5 1 0
Nursing 2 2 1.0 1 1
Nutrition & Dietetics 2 0 0.0 2 2
Pathology 2 4 2.0 2 0
Veterinary Sciences 2 18 9.0 2 2
Total 390 2516 6.5 289 135
doi:10.1371/journal.pone.0017428.t002
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52.59. In addition, 61.4% of the papers were published in the first,
second, or third ranked journal within their respective fields, based
on the ranking of journals by Eigenfactor scores. The performance
and impact indicators for the 72 papers above the 10% highly
cited threshold by category are listed in Table 3.
To assess the scientific impact that these upper-tier publications
might be generating, we again used the journal normalized
citation score and the field normalized citation score. Collectively,
the results revealed this set of 72 papers were performing at a very
high level and far exceeded the average citations for papers of the
same type, age, and within the same journal. The citations per
paper (CPP) across all categories were high. More specifically, the
papers publishing primary study results, secondary analyses results,
and collaborative study results were found to far exceed the
expected number of citations when compared to papers in the
same journals and fields. This highlighted their widespread
presence, performance and impact across global HIV research
environments and confirmed their highly-cited threshold status
and influence relative to similar papers in the journals in which
they were published.
Co-authorship and collaboration patterns
Analysis of co-authorship patterns is frequently used in
advanced bibliometric studies as a means for understanding
collaboration. In assessing the degree of collaboration across the
NIAID HIV/AIDS clinical trials networks’ studies, we examined
the co-authorship patterns. A total of 2,834 authors were listed
across the 419 papers. We found 11 authors on average for each
paper submitted by the NIAID HIV/AIDS clinical trials networks,
indicating a high degree of co-authorship. The wide range of
authors was a factor in the breadth of scientific specialties,
resulting in a relatively low disciplinarity score for these
publications. Specifically, a disciplinarity score is a measure that
reflects the level of multidisciplinarity in a set of papers. Often
referred to as the Herfindal index, this metric range is from 0–1
and equals the sum of squares of disciplinary shares for the set.
The lower the number is, the more multidisciplinary the group of
papers [30]. In the full set, we found the network papers reflect a
fairly wide range of disciplines due to its relatively low
disciplinarity score (0.14). Furthermore, the degree of international
collaboration based on co-author relationships was considerable,
with US-based authors collaborating with authors in 41 different
countries on a total of 243 papers. As the largest HIV/AIDS
clinical trials research system in the world, this finding was not
surprising and confirmed the extensive involvement of interna-
tional investigators and their contributions to the clinical trials
research networks.
In an effort to visually model the interdisciplinary of the NIAID
HIV/AIDS clinical trials networks-funded research, we first
created a co-authorship network for the 72 highly-cited articles.
Disambiguation of author names is a central issue in collaboration
network analysis and strategies range from complex algorithms to
manual cleaning depending on the size of the data set and purpose
of the analysis [31]. Given our purpose to model a co-authorship
network using a small subset of papers, we manually reviewed and
verified each of the 72 highly cited network papers in the WoS
database to identify any ambiguities. Upon the validating the
correct full bibliographic record paper in the WoS, we used the
author’s initials and institutional affiliation to clarify any multiple
occurrences of similar names to ensure an accurate match of
authors. This cleaned list of highly cited papers was downloaded in
a field tagged format and a co-authorship analysis was conducted
using CiteSpace software developed for network analysis and
visualization based on publication data [32]. We then subjected
the network output to a clustering method specifically designed to
represent local interactions among subunits of a larger system
using links and nodes in directed, weighted networks [33]. In
modeling the intra-network connectivity of highly-cited papers, we
sought visual simplicity and the most parsimonious representation
of a complex set of collaborative relationships revealed in the co-
author pairings. Figure 2 displays the co-authorship network for
the most productive author relationship clusters or modules for the
set of 72 papers above the 10% highly-citied threshold.
Each module includes a group of nodes (i.e. authors), which are
aggregated into a single well-connected module. The original 634
nodes from the network analysis output were clustered into 44
modules, connected by 103 inter-module links. Links between
modules represent pair-wise relationships where the more heavily
weighted links (i.e. thicker lines) indicated greater co-author
pairing between modules. As shown in Figure 2, every module
represents a cluster of nodes and the links between the modules
represent the flow between the modules, in this case the co-
authorship pairings. Each module was then labeled to represent
the network from which the aggregated set of authors was
affiliated, providing a coarse grained view of cross-network
collaboration on the highly-cited papers.
Through the examination of the extensive co-authorship
network, we observed the emergence of co-authorship patterns
of the highest performing papers over the three year period across
the entire NIAID HIV/AIDS clinical trials system. Overlaying the
Table 3. Performance and Impact indicators for the 72 papers at the 10% highly-cited level by publication type.
Type P C CPP CPP/JCSm CPP/FCSm JCSm/FCSm
Total 72 1522 21.14 1.74 5.42 3.11
Primary study 22 528 24.0 1.66 6.62 4.02
Secondary study 13 216 16.62 3.38 5.77 1.75
Review article 9 219 24.33 1.05 4.90 4.49
Cross-protocol study 4 72 18.0 .84 3.27 3.93
Collaborative/external study 17 419 24.65 2.48 5.17 2.12
Observational study 4 18 4.50 1.95 4.69 2.08
Other 3 50 16.67 2.29 3.95 1.81
Note: P=number of articles published; C=total number of citations; CPP=average number of citations per publication; JCSm=average expected citations for a journal
set; FCSm=average expected citations across a combination of fields.
doi:10.1371/journal.pone.0017428.t003
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and collaboration between researchers from different parts of the
system. The prominence of ACTG-supported research was
evident in the model. This network has the longest history and
largest infrastructure for conducting HIV/AIDS clinical trials
research. As such, ACTG submitted the most publications and
had the largest number of papers in the highly-cited group. While
larger module size corresponds to the relative significance in the
network, several important connections between smaller collabo-
rative groups who function as bridges to different, but related
research communities were also found. For example, in the lower
left hand corner of the network map is a group focused on
preventive vaccine trial research (supported by HVTN). Connect-
ed to this group of researchers by virtue of their shared author
teams, are multiple groups of scientists focused on non-vaccine
prevention trial research (supported by HPTN). Similarly, we
found several instances where author teams focused on both
preventive non-vaccine and preventive vaccine trial research were
connected to therapeutic and translational research (supported by
ACTG) research groups. The connections observed between these
research teams suggest collaborative interactions across research
foci and reflects the integration of prevention and treatment
Figure 2. A 44-cluster co-authorship network of papers at the 10% highly-cited threshold.
doi:10.1371/journal.pone.0017428.g002
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Overall, the visualization of co-authorship patterns at the highest
level of publication productivity revealed greater cross-network
collaboration than what could be extracted from a general review
of author teams and affiliations found in the bibliographic record.
Inclusion of papers in research syntheses
Unfortunately the gap between clinical research findings and
clinical practice implementation in many areas of health care and
public health is large, well documented, and disconcerting [34].
Assessing the progression of scientific output, as initial research
findings move on their way to becoming improvements in clinical
practice, provides some insight into the translation of publicly
funded research development from new basic insights into use in
the public’s health care. As clinical research is disseminated
through the peer-reviewed literature to others in the field it
becomes available for inclusion by those who are responsible for
conducting research syntheses and/or developing guidelines to aid
in determining clinical practice. Eventually these syntheses and
guidelines are practically applied by medical staff and health
program developers when implementing or adjusting healthcare
programs to accommodate the advancements in therapies and
other treatments. Following the simple, but logical path of
awareness in the literature, acceptance in the synthesized research,
and adoption into practice [35] we sought to determine the extent
to which network publications were cited in synthesized reviews.
We found 187 papers from the set of 419 publications from the
NIAID HIV/AIDS clinical trials networks were cited by 365
review articles published between 2006 and 2009. As categorized
by JCR, citing reviews can encompass a range of syntheses,
including reviews of the literature, clinical practice guidelines, and
meta-analyses. The 187 network papers found in these reviews
were top performing publications with 63 (33.7%) found to be
above the 10% highly-cited threshold. More than half of the 187
papers (52.4%) were published in 2006, 36.9% in 2007, and
10.7% in 2008. In terms of the type of reviews citing network
papers, 348 of the 365 were classified as general literature reviews
of the research. In addition, we found a small set of specialized
research syntheses. Within this subset of research syntheses were
11 practice guidelines (directions or principles to assist the health
care practitioner with patient care decisions about appropriate
diagnostic, therapeutic, or other clinical procedures for specific
clinical circumstances), 5 meta-analyses (studies using a quantita-
tive method of combining the results of independent studies that
address a set of related research hypotheses), and 1 general
guideline (statements, directions, or principles presenting current
or future rules or policy focused on general conduct and
administration of health care activities). The number of NIAID
HIV/AIDS clinical trials network research papers cited in the 348
research literature reviews was 159, and 28 network papers were
cited in the 17 specialized research syntheses. In order to
determine the performance and impact of the NIAID HIV/AIDS
clinical trials network publications included in these reviews and
syntheses, citation data was aggregated and analyzed according to
type using the same metrics used previously in this report. The
results are represented in Table 4 and confirm the wide
recognition and use of these publications across journals and
fields of relevance to HIV research. These results suggest that a
large proportion of network produced papers was of special
interest to those synthesizing the current research, and were
performing well above average and influential across HIV-related
fields.
The 365 citing reviews were published in 196 different journals,
and to date had received a total 1752 cites with an average of 5
cites per paper. These reviews were distributed across 52 different
fields, with the greatest number of reviews and syntheses found in
Pharmacology and Pharmacy (98), Infectious Disease (91), and
Immunology (88). Using a number of different PubMed search
filters, we identified major research support categories for the set of
citing reviews, providing a sense of the primary funding support
for the reviews that included papers from the NIAID HIV/AIDS
clinical trials networks. Slightly more than one-third of the review
articles were identified as non-US Government supported
research. Research reviews and syntheses in this category are
supported by domestic societies, institutes, state governments,
universities, private organizations, as well as by foreign govern-
ments, academic institutions and private organizations. Moreover,
one-quarter of the research reviews were supported by NIH
sources, both intramural and extramural, and another quarter
were supported by the federal Public Health Service (PHS), its
bureaus, and services.
Collectively, these findings suggest that, despite the very short
publication life of the papers from the NIAID HIV/AIDS clinical
trials networks, their uptake in the synthesized research base had
already been initiated. Previous research found an 8-year lag-time
between publication of a cited paper and the publication of
guidelines in the UK, suggesting a substantial delay in the
appearance of research findings in the practice-based literature
[36]. The rapid inclusion of papers from the DAIDS networks in
guidelines and meta-analyses is notable; as it is expected that
acceptance of the research output in reviews and syntheses will
increase across the entire set of papers over time.
Discussion
This study used advanced bibliometric methods to evaluate the
presence, performance, and impact of peer-reviewed publications
from the NIAID HIV/AIDS clinical trials networks from 2006–
2008. Through this approach, we sought to expand traditional
bibliometric analyses beyond citation counts to include normative
comparisons, network analysis and visualization techniques, and
assessment of inclusion in reviews and syntheses. Expanding
descriptive and inferential bibliometric methods are especially
important in new research frontiers like prevention [37], as well as
in very collaborative and cross-disciplinary environments. Overall,
the scientific publications from the NIAID HIV/AIDS clinical
trials networks were slightly above the average number of citations
worldwide controlling for the journals in which they were
published. Papers from the networks were published in journals
Table 4. Performance and impact indicators for NIAID HIV/
AIDS clinical trials networks publications cited in research
reviews and syntheses, 2006–2009.
Set P C CPP
CPP/
JCSm
CPP/
FCSm
JCSm/
FCSm
Research literature
review
159 1503 9.45 1.23 2.19 1.80
Practice guidelines 18 514 28.56 1.44 5.79 4.01
General guidelines 5 79 15.80 3.70 5.31 1.44
Meta-analyses 5 94 18.80 2.37 3.70 1.56
Note: P=number of articles published; C=total number of citations;
CPP=average number of citations per publication; JCSm=average expected
citations for a journal set; FCSm=average expected citations across a
combination of fields.
doi:10.1371/journal.pone.0017428.t004
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part, publications were found in highly recognized journals
suggesting that network research is being disseminated to a large
audience across AIDS-related fields. The daily practice of scientific
research shows that scientists generating high quality research
generally aspire to publish in the best journals, especially in the
natural, biomedical, and medical sciences [23]. The presence of
publications from the NIAID HIV/AIDS clinical trials networks
at elevated levels of the journal hierarchy confirmed the scientific
output was of high quality and researchers’ work was meeting
rigorous peer review standards for publication.
Self-citation rates were not unusual and did not contribute to
greater than expected citation levels. While the set of papers from
the NIAID HIV/AIDS clinical trials networks reached the
expected level of performance, substantive impact was associated
with a set of highly-cited publications. This collection of papers
received significantly greater number of citations than what was
expected, suggesting these papers were widely recognized by other
scientists across the AIDS research environments. Moreover, the
multidisciplinary nature of the NIAID HIV/AIDS clinical trials
networks was evident in the high number of average authors per
paper, the variety of journals, and the breadth of fields represented
by the journals. The extensive global network of collaborative
scientists was apparent through the international representation on
author teams as well as the visual linkages found between highly
productive author groups functioning as information brokers.
Research from the NIAID HIV/AIDS clinical trials networks
was represented in published guidelines, both policy and
procedural as well as clinical practice, highlighting the value of a
subset of research output in shaping healthcare service delivery.
The inclusion of NIH-sponsored clinical trials research, in reviews
supported by non-US government sources (domestic and interna-
tional) signals a broad acknowledgement and acceptance of the
scientific output across a diverse scientific infrastructure. As a
world leader in AIDS research, it is important that evaluation and
monitoring of scientific output from the research networks include
the translation of publicly-funded clinical research into clinical
practice. Most clinicians’ knowledge of published research is
incomplete due to poor presentation research findings [38], lack of
time to search for information, findings dispersed across large
number journals [39], and difficulty in interpreting published
evidence [38]. Reviews often address these problems by acting as
the aggregators of current clinical research and serve as a source
for evaluating the use of scientific results.
Implications
Bibliometric assessment of research presence, performance, and
impact has been based on a core assumption that scientists with
important information actively seek to publish their findings in
open, international journals [23]. Research scientists within the
NIAID HIV/AIDS clinical trials networks are no different. With
the focus of the networks on clinical trials research for HIV
prevention and treatment, the dissemination and use of results
within the professional literature is a widely accepted aspect of
documenting the scientific accomplishments.
The results of this advanced bibliometric analysis have several
important implications for evaluation and monitoring of the
scientific output of the NIAID HIV/AIDS clinical trials networks
and potentially other clinical trials consortia. First, this biblio-
metric study revealed key data collection and retrieval consider-
ations. Going forward, specific guidance for recording and
verifying bibliographic records will be critical to ensuring an
appropriate match between network publications and citation data
extracted from multiple bibliometric databases. Furthermore, as
the multidisciplinary nature of the network publications continues
to expand, important bibliometric data may need to be accessed
and verified from other citation tracking databases, such as
PubMed, Google Scholar and Scopus in addition to those found in
WoS. Second, the variety of disciplinary fields found to contain
network publications revealed variable expectations in terms of
relative performance and impact. Thus, ongoing evaluation and
monitoring of publication presence, performance, and impact
should include analysis by field, with comparisons made to
worldwide citation and publication measures. Normalization of
citation and journal influence data from the international set of
journals and fields is required for accurate assessment and
comparison to determine the levels of presence, performance,
and impact. Third, the results of the bibliometric study provide a
baseline level of presence, performance, and impact, and suggest a
set of potential indicators that may be applied to future analysis of
output from the networks. For example, measures such as the
‘‘percent of network papers published in the top quartile of the
respective fields’’ or the ‘‘percent of papers at the 10% threshold’’
may be employed in the future as indicators of enterprise research
performance. Since papers at the 10% highly cited threshold were
highly influential within the journals and fields in which they were
published, setting expectations for increasing the number of papers
reaching the threshold would quickly indicate the progress the
networks were making toward meeting the objective of producing
impactful research. Finally, in this study we examined the use of
unique bibliometric techniques that, with further refinement, may
provide a more robust picture of performance and impact beyond
traditional citation analyses. Specifically, the examination of the
presence of network papers in research syntheses extends the
understanding of how and in what ways the scientific research
produced by the networks is being utilized. The use of clinical
guidelines as an intermediate indicator of research utility in the
translational process [36] can provide a clearer picture of the
downstream impact network research may be generating in terms
of stimulating new research, supporting and confirming existing
knowledge, or shaping clinical practices.
Moreover, while visualization techniques like those employed
here may appear to be somewhat limited as a tool for evaluating
performance or impact, they have utility as a heuristic for
monitoring author or subject collaboration and identifying cross-
network research efforts associated with high performance and
impact. Indeed, similar network assessments have confirmed the
widespread belief that many research frontiers are being driven by
cross-fertilization of ideas, interdisciplinary collaborations, and
further integration of scientific disciplines [40]. Moreover, network
analysis and visualization techniques can be used to monitor
strategic goals such as integration and collaboration across
research areas over time. New methods are emerging that enable
a more precise assessment of co-authorship impact on scientific
publications and are particularly useful in interdisciplinary
research environments where contributions are widely distributed
[41]. Advanced bibliometric techniques, integrated systematically
with other methods for assessing the full range of impact of
scientific output, can yield important information for evaluation
and monitoring an entity’s productivity.
Limitations
Although bibliometric methods have expanded across the
research evaluation landscape issues related to coverage, commu-
nication practices among scholars and language have been noted
[42]. For example, bibliometric analyses can only be applied to the
published literature in journals that are indexed with respect to
citations and do not cover unpublished works, works in non-
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dissertations, reports, or government documents. Citations are also
treated as equal regardless of whether a work is being cited for its
positive contribution to a field or being criticized as for its negative
impact or poor quality. Different authors employ differing levels of
care in compiling references and differences in citation tracking
across databases remains a concern. The determination of impact
through the exclusive use of bibliometric measures has received
widespread criticism from the scientific community. Plenty has
been written on the deleterious effects of the misuse of bibliometric
data in judging rank, output, and value [43–45]. Caution must be
employed in emphasizing the scientific quality of the research
output solely on the basis of bibliometric data.
As with any statistical endeavor, bibliometric analyses have the
potential to generate misleading and biased results. Because
citation counts are time, type and field dependent, adjustment to
the expected patterns for citations must be taken into account
when comparing performance and impact. Although it is common
for clinical trials papers to have large author teams, the average
number of authors across papers was high. A large set of diverse
authors on papers may increase the likelihood of an elevated
number of citations and thus affect the assessment of performance.
In future studies, it might be important to control for the number
of authors to avoid inflated citation counts and more precise
estimates of performance and impact. In addition, given the brief
assessment period, a large proportion of the papers did not have
an opportunity to establish their presence in the publication
domain. Therefore, our analysis may not have captured the full
variability of citations patterns of a completely mature set of
publications. Nonetheless, where possible, we sought to isolate
publication groups and normalize citation data to more precisely
determine relative impact. Standard bibliometric techniques are
well suited for assessing the contribution to the advancement of
knowledge, but much less so in assessing contributions to mission-
oriented objectives of research institutions, such as impacts to
population health or collaboration among scientists. In addition,
we attempted to examine some of the initial translational patterns
in scientific output using bibliometric methods. However, our
ability to do so was fairly limited, compounded by well-known
issues in determining downstream effects of research outputs and
the integration of different citation databases. Thus, these results
are merely suggestive of the movement of the clinical research
output from awareness to acceptance.
Conclusion
Despite the limitations, advanced evaluative bibliometric
analyses such as those conducted here, can be used to explicate
and describe patterns of performance and impact of scientific
research across a multidisciplinary research enterprise. At the
management and policy level, bibliometric analysis has been
identified as one of the tools that have potential to assist decision-
makers in understanding science and innovation, investing in
science and innovation, and using the ‘‘science of science’’ policy
to address national priorities [46,47]. Any publicly funded
research enterprise must be held accountable for its productivity
and advanced bibliometric analyses offer a set of sophisticated
tools that can provide important evidence during evaluation. As a
means for assessing scientific output, bibliometrics can help create
a data-driven picture of scientific research within the publication
landscape and offer evidence-based descriptions, comparisons, and
visualizations of research output.
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